Annals of vascular surgery · 2026
Long-Term Outcomes of Hybrid Treatment for Thoracoabdominal Aortic Aneurysms: A 19-year Single-Center Experience.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shuto Takashi, Kawashima Takayuki, Hongo Norio, Asayama Yoshiki, Miyamoto Shinji
Аннотация
BACKGROUND: Open surgical repair for thoracoabdominal aortic aneurysms (TAAAs) is associated with substantial perioperative morbidity and mortality, especially in elderly or comorbid patients. Hybrid repair-visceral debranching combined with thoracic endovascular aortic repair-was introduced at our institution in 2007 to reduce operative stress while maintaining durable outcomes. This study evaluates the long-term results of this approach over a 19-year experience.
METHODS: We retrospectively analyzed 78 patients who successfully underwent hybrid TAAA repair and were discharged between 2007 and 2025. Long-term outcomes focused on aneurysm-related events and the need for reintervention.
RESULTS: Fifty-four patients (69.2%) were male, with a mean age of 73 years (range, 44-89). Twenty-two patients (28.2%) were ≤70 years, 26 (33.3%) were in their seventies, and 30 (38.5%) were in their eighties. Overall survival was 67.0% ± 5.4% at 5 years and 30.9% ± 6.3% at 10 years. Freedom from aneurysm-related events was 98.5% ± 1.5% at 5 years and 77.2% ± 9.4% at 10 years. Freedom from reintervention was 85.0% ± 4.6% at 5 years and 54.8% ± 10.0% at 10 years. Aneurysm enlargement occurred in 29 patients (41.4%), and 17 patients (21.8%) underwent reintervention for endoleaks (type I: 5, type II: 4, type III: 8). Endoleak was the only factor significantly associated with aneurysm enlargement.
CONCLUSION: Despite the need for late reintervention, hybrid repair provides a high aneurysm-related event-free rate at 10 years when endoleaks are appropriately managed. Hybrid repair remains a valuable treatment option for high-risk patients, particularly in centers without full endovascular capability and in patients who are anatomically unsuitable for total endovascular repair.
METHODS: We retrospectively analyzed 78 patients who successfully underwent hybrid TAAA repair and were discharged between 2007 and 2025. Long-term outcomes focused on aneurysm-related events and the need for reintervention.
RESULTS: Fifty-four patients (69.2%) were male, with a mean age of 73 years (range, 44-89). Twenty-two patients (28.2%) were ≤70 years, 26 (33.3%) were in their seventies, and 30 (38.5%) were in their eighties. Overall survival was 67.0% ± 5.4% at 5 years and 30.9% ± 6.3% at 10 years. Freedom from aneurysm-related events was 98.5% ± 1.5% at 5 years and 77.2% ± 9.4% at 10 years. Freedom from reintervention was 85.0% ± 4.6% at 5 years and 54.8% ± 10.0% at 10 years. Aneurysm enlargement occurred in 29 patients (41.4%), and 17 patients (21.8%) underwent reintervention for endoleaks (type I: 5, type II: 4, type III: 8). Endoleak was the only factor significantly associated with aneurysm enlargement.
CONCLUSION: Despite the need for late reintervention, hybrid repair provides a high aneurysm-related event-free rate at 10 years when endoleaks are appropriately managed. Hybrid repair remains a valuable treatment option for high-risk patients, particularly in centers without full endovascular capability and in patients who are anatomically unsuitable for total endovascular repair.
Предметные рубрики MeSH
HumansAortic Aneurysm, ThoracoabdominalMaleEndovascular Aneurysm RepairRetrospective StudiesTime FactorsBlood Vessel Prosthesis ImplantationAgedEndovascular ProceduresMiddle AgedRisk FactorsAdultFemaleAged, 80 and overPostoperative ComplicationsTreatment OutcomeProgression-Free SurvivalEndoleakReoperationBlood Vessel ProsthesisAortic Aneurysm, Thoracic